Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of cancer and infectious diseases. Their proprietary discovery platform allows them to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.